We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $103M
1-Year Est. Return 77.32%
This Fund
S&P 500
This Quarter Est. Return
+20.64%
1 Year Est. Return
+77.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$83.8M
AUM Growth
-$9.56M
Cap. Flow
-$15.6M
Cap. Flow %
-18.56%
Top 10 Hldgs %
54.2%
Holding
117
New
40
Increased
13
Reduced
18
Closed
44

Top Buys

Rank Stock Value
1
PRTA icon
Prothena Corp
PRTA
+$5.37M
2
SAGE
Sage Therapeutics
SAGE
+$2.54M
3
ITOS
iTeos Therapeutics
ITOS
+$2.43M
4
SKX
Skechers
SKX
+$2.07M
5
SGRY icon
Surgery Partners
SGRY
+$1.67M

Top Sells

Rank Stock Value
1
BUR icon
Burford Capital
BUR
+$3.92M
2
CLMT icon
Calumet Specialty Products
CLMT
+$2.55M
3
AMPY icon
Amplify Energy
AMPY
+$2.5M
4
LQDA icon
Liquidia Corp
LQDA
+$2.36M
5
PARR icon
Par Pacific Holdings
PARR
+$2.02M

Sector Composition

Rank Sector Weight
1 Healthcare 46.94%
2 Energy 12.53%
3 Real Estate 8.38%
4 Consumer Discretionary 7.77%
5 Materials 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BFIN
76
DELISTED
BankFinancial
BFIN
– –
-89,000
Closed -$1.12M
BLCO icon
77
Bausch + Lomb
BLCO
$5.85B
– –
-15,000
Closed -$218K
CDLX icon
78
Cardlytics
CDLX
$22.7M
– –
-13,000
Closed -$237K
CEE
79
Central and Eastern Europe Fund
CEE
$135M
– –
-113,892
Closed -$1.64M
CLMT icon
80
CALL
Calumet Specialty Products
CLMT
$3.59B
– –
-6,000
Closed -$76.1K
CORZ icon
81
Core Scientific
CORZ
$6.42B
– –
-86,400
Closed -$626K
DESP
82
DELISTED
Despegar.com
DESP
– –
-29,702
Closed -$558K
ESPR
83
DELISTED
Esperion Therapeutics
ESPR
– –
-92,500
Closed -$133K
FPH icon
84
Five Point Holdings
FPH
$393M
– –
-14,851
Closed -$79.3K
FSEA icon
85
First Seacoast Bancorp
FSEA
$79.5M
– –
-13,000
Closed -$151K
GAN
86
DELISTED
GAN Ltd
GAN
– –
-59,912
Closed -$106K
GES
87
DELISTED
Guess Inc
GES
– –
-15,000
Closed -$166K
HGV icon
88
Hilton Grand Vacations
HGV
$4.06B
– –
-42,000
Closed -$1.57M
HHH icon
89
Howard Hughes
HHH
$3.94B
– –
-4,781
Closed -$354K
HYG icon
90
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
– –
-7,500
Closed -$592K
INBX icon
91
Inhibrx
INBX
$1.17B
– –
-17,810
Closed -$249K
JACK icon
92
Jack in the Box
JACK
$307M
– –
-44,000
Closed -$1.2M
LBRDA icon
93
Liberty Broadband Class A
LBRDA
$4.69B
– –
-16,500
Closed -$1.4M
LQDA icon
94
Liquidia Corp
LQDA
$7.53B
– –
-160,000
Closed -$2.36M
LYEL icon
95
Lyell Immunopharma
LYEL
$316M
– –
-500
Closed -$5.38K
MAPS
96
DELISTED
WM TECHNOLOGY INC A
MAPS
– –
-125,000
Closed -$141K
PARR icon
97
Par Pacific Holdings
PARR
$3.96B
– –
-141,687
Closed -$2.02M
PDLB icon
98
Ponce Financial Group
PDLB
$498M
– –
-14,781
Closed -$187K
ROIV icon
99
Roivant Sciences
ROIV
$24.5B
– –
-140,178
Closed -$1.41M
SHC icon
100
Sotera Health
SHC
$5.01B
– –
-14,000
Closed -$163K
1 2 3
4
5

Similar funds

EFT
Envision Financial Transparency Greensboro, North Carolina $103M AUM
GWL
Generations Wealth LLC Mason, Ohio $103M AUM
CC
Caspian Capital New York $103M AUM
ABLA
Alan B. Lancz & Associates Toledo, Ohio $103M AUM 31.99% 1-Year Est. Return
SPCM
Stoic Point Capital Management Palo Alto, California $103M AUM
OPAM
Olympus Peak Asset Management Greenwich, Connecticut $103M AUM 58.06% 1-Year Est. Return
ES
ETF Store Overland Park, Kansas $103M AUM 15.78% 1-Year Est. Return
IMT
Investment Management Trust Fitchburg, Massachusetts $103M AUM

Rangeley Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Rangeley Capital held 117 positions worth $83.8M, down 10% from $93.4M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Rangeley Capital withdrew a net $15.6M in Q2 2025, closing 44 positions and reducing 18 holdings. Its most notable exit was Liquidia Corp, an estimated $2.36M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 29% a quarter earlier, followed by Energy and Real Estate.

Against the trend, Rangeley Capital opened a new position in Prothena Corp worth $4.34M.

  • Rangeley Capital's largest Q2 2025 buy was Prothena Corp: 715,367 shares worth $4.34M.
  • Rangeley Capital added most to Sage Therapeutics in Q2 2025, an estimated $2.54M increase.
  • Rangeley Capital's biggest Q2 2025 reduction was Burford Capital, cutting an estimated $3.92M.
  • Rangeley Capital fully exited Liquidia Corp in Q2 2025, selling an estimated $2.36M.
  • Rangeley Capital's ten largest holdings make up 54% of its $83.8M portfolio in Q2 2025.
  • Rangeley Capital opened 40 new positions and closed 44 in Q2 2025.
  • Rangeley Capital's portfolio value fell 10% quarter-over-quarter to $83.8M.

Based on Rangeley Capital's 13F filing for Q2 2025, filed 14 Aug 2025.